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Virulence from vesicles: Novel 
mechanisms of host cell injury by 
Escherichia coli O104:H4 outbreak 
strain
Lisa Kunsmann1, Christian Rüter2, Andreas Bauwens1, Lilo Greune2, Malte Glüder1, 
Björn Kemper3, Angelika Fruth4, Sun Nyunt Wai5, Xiaohua He6, Roland Lloubes7, 
M. Alexander Schmidt2, Ulrich Dobrindt1, Alexander Mellmann1, Helge Karch1 & 
Martina Bielaszewska1
The highly virulent Escherichia coli O104:H4 that caused the large 2011 outbreak of diarrhoea 
and haemolytic uraemic syndrome secretes blended virulence factors of enterohaemorrhagic and 
enteroaggregative E. coli, but their secretion pathways are unknown. We demonstrate that the 
outbreak strain releases a cocktail of virulence factors via outer membrane vesicles (OMVs) shed 
during growth. The OMVs contain Shiga toxin (Stx) 2a, the major virulence factor of the strain, 
Shigella enterotoxin 1, H4 flagellin, and O104 lipopolysaccharide. The OMVs bind to and are 
internalised by human intestinal epithelial cells via dynamin-dependent and Stx2a-independent 
endocytosis, deliver the OMV-associated virulence factors intracellularly and induce caspase-9-
mediated apoptosis and interleukin-8 secretion. Stx2a is the key OMV component responsible for the 
cytotoxicity, whereas flagellin and lipopolysaccharide are the major interleukin-8 inducers. The OMVs 
represent novel ways for the E. coli O104:H4 outbreak strain to deliver pathogenic cargoes and injure 
host cells.
Escherichia coli O104:H4, which caused a massive outbreak in 2011 with nearly 4000 infected persons, 
more than 900 cases of haemolytic uraemic syndrome (HUS) and 54 deaths1, is a hybrid of entero-
haemorrhagic (EHEC) and enteroaggregative (EAEC) E. coli2–4. The strain harbours blended EHEC and 
EAEC virulence genes2–4 and expresses phenotypes typical for each pathotype including the production 
of Shiga toxin (Stx) 2a, the cardinal virulence factor of EHEC, and “stacked-brick” aggregative adherence 
to cultured human intestinal epithelial cells, a defining characteristic of EAEC2. Stx2a is encoded in the 
genome of a prophage inserted into the E. coli O104:H4 chromosome3,4. The chromosome also encodes 
additional EHEC virulence characteristics such as Iha (the iron-regulated gene A homologue adhesin), 
and tellurite resistance, as well as EAEC virulence factors including ShET1 (Shigella enterotoxin 1), and 
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the serine protease autotransporters of Enterobacteriaceae (SPATEs) Pic (protein involved in intestinal 
colonisation), and SigA (Shigella IgA protease-like homologue)3,4. Additional virulence factors of EAEC, 
including aggregative adherence fimbriae I (AAF/I), the transcriptional regulator AggR, SPATE SepA 
(Shigella extracellular protein A), dispersin, and the dispersin transporter, are encoded on a 75 kb pAA 
plasmid3,4. Clinical observations and studies in animal models and tissue cultures indicate that Stx2a, the 
SPATEs Pic and SigA, as well as the pAA-encoded virulence factors, in particular AAF/I, contributed to 
the high pathogenicity of the outbreak strain5–8.
Virulence factors are secreted from bacterial pathogens and delivered into the host cells (i) as free, 
soluble proteins, which interact with target cells via receptor-mediated or receptor-independent mech-
anisms, (ii) via macromolecular syringes, which inject the proteins directly into the cytosol, and (iii) 
in association with outer membrane vesicle (OMVs), which are spherical, bilayered nanostructures 
constitutively released by multiple bacteria9–12. The association with OMVs protects virulence factors 
from inactivation by degradative enzymes within the host tissues and enables a direct, simultaneous 
and coordinated delivery of the virulence factors into host cells11,12, that could increase their pathogenic 
potential. Moreover, because they also contain antimicrobial substances and immunomodulatory com-
pounds, OMVs act as highly efficient weapons that assist bacterial pathogens to establish their coloniza-
tion niches, impair host cellular functions, trigger inflammatory responses, and modulate host defense 
(reviewed in10,11). The key role of OMVs in bacterial virulence is supported by their ability to mimic in 
animal models diseases caused by the parental pathogens13.
It is presently unknown in which forms the outbreak strain secretes its virulence factors, in particular 
whether or not it releases OMVs and which role(s) they may play in its virulence. We identified and 
characterised OMVs from the E. coli O104:H4 outbreak strain and analysed them for virulence factors 
of this pathogen. We investigated the interactions of the OMVs with intestinal epithelial cells (IECs), 
which are the first cellular targets for E. coli O104:H4 during human disease, and determined biological 
consequences of such interactions.
Results
E. coli O104:H4 outbreak strain releases OMVs. Electron microscopy of Luria-Bertani (LB) agar 
culture of E. coli O104:H4 outbreak strain LB226692 demonstrated blebbing of OMVs from the bacte-
rial surface (Fig. 1a–c) as well as free OMVs that had already been released from bacteria (Fig. 1b). The 
OMVs were surrounded by a membrane bilayer (Fig.  1b), which, like the bacterial outer membrane, 
was detected by an antibody against the E. coli O104 lipopolysaccharide (LPS) (Fig. 1a,b) indicating that 
the OMV membrane has been derived from the bacterial outer membrane. In liquid culture, the OMV 
production correlated with bacterial growth, being most rapid during logarithmic phase (Fig.  1d,e). 
The kinetics of OMV production and the OMV amounts were similar in the stx2a-harbouring strain 
LB226692 (Fig. 1d) and a stx2a-negative derivative of the outbreak strain, C227-11Φ cu (Fig. 1e).
OMV-associated DNA and virulence genes. DNA was identified in DNase untreated as well as 
DNase-treated OMVs, both intact and lysed after the DNase treatment (Supplementary Table S1). In PCR 
analyses, DNase untreated LB226692 and C227-11Φ cu OMVs produced amplicons for all virulence loci 
found in the respective parental strains including chromosomal (stx2a, iha, terZABCDEF cluster, pic, sigA, 
set1, fliCH4), and pAA-encoded (aggR, aggA, sepA, aap, aatA) (Supplementary Table S2). DNase-treated 
OMVs produced amplicons for stx2a and ter genes only (Supplementary Table S2) suggesting that the 
DNA harbouring these loci is packaged inside OMVs, whereas the other DNA is associated with OMV 
surface. This was confirmed by amplification of stx2a and ter genes, but not of the other virulence loci, 
from density gradient-purified OMVs (Supplementary Table S2).
Protein composition of E. coli O104:H4 OMVs. Protein profiles of LB226692 and C227-11Φ cu 
OMVs determined by gel electrophoresis followed by silver staining were similar albeit not identical 
(Fig.  1f). Nano-LC-MS/MS analysis identified 77 proteins (67 in both OMV preparations), including 
outer membrane, periplasmic, inner membrane, cytoplasmic, extracellular, and proteins with unknown 
localisation (Supplementary Table S3). The percentual distribution of OMV-associated proteins accord-
ing to their subcellular localisation is shown in Fig.  1g. Stx2a and H4 flagellin were the major viru-
lence factors identified in LB226692 OMVs, whereas only flagellin was found in C227-11Φ cu OMVs 
(Supplementary Table S3).
OMVs contain a subset of virulence factors of E. coli O104:H4 outbreak strain. To identify 
additional E. coli O104:H4 virulence factors within OMVs, we analysed OMVs and OMV-free superna-
tants from strains LB226692 and C227-11Φ cu for outer membrane protein A (OmpA; an OMV marker), 
Stx2a, ShET1, Pic, SigA, SepA, AAF/I A subunit, and H4 flagellin by immunoblot. Stx2a was identified 
both in OMVs (30% of the total Stx2a produced by strain LB226692) and in OMV-free supernatant 
(70%) (Fig. 2a). H4 flagellin was almost equally distributed between OMVs and OMV-free supernatants 
of strains LB226692 (44% and 56%, respectively) and C227-11Φ cu (41% and 59%, respectively) (Fig. 2a). 
In contrast, ShET1 was solely associated with OMVs, whereas Pic, SigA, SepA, and AAF/I A subunit 
were found only in OMV-free supernatants (Fig. 2a).
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Figure 1. E. coli O104:H4 outbreak strain releases OMVs. (a–c) Immunogold staining of ultrathin frozen 
sections of an overnight LB agar culture of strain LB226692 using (a,b) anti-E. coli O104 LPS antibody 
and Protein A Gold (10 nm gold particles) or (c) only Protein A Gold (control). The inset in panel (b) 
(bottom) shows magnification of the indicated region. Frames (top) delineate OMVs that were located at 
longer distances from the OMV-producing bacteria and were thus detected in different microscopic fields. 
Examples of bacterial cells (b) and OMVs (v) are indicated. Scale bars are 300 nm, in the inset in panel 
(b) 100 nm. The images were acquired with a FEI-Tecnai 12 electron microscope. (d,e) Kinetics of OMV 
production. Strains LB226692 (d) and C227-11Φ cu (e) were grown in LB broth, OMVs were isolated at 
indicated time points and analysed using immunoblotting with anti-OmpA antibody. Signals were visualised 
with Chemi Doc XRS imager, quantified using Quantity One® software, and expressed in arbitrary 
densitometric units (DU). OMV-free supernatants served as controls. Bacterial growth was monitored by 
measuring OD600. Data are means ± standard deviations from three independent experiments. (f) Protein 
profiles of LB226692 (lane 1) and C227-11Φ cu (lane 2) OMVs determined by SDS-PAGE and silver staining. 
M, Marker IV (Peqlab Biotechnologie); the sizes of the bands are shown on the left side. (g) Distribution 
of OMV-associated proteins identified using nano-LC-MS/MS according to their subcellular localisation as 
determined by PsortB prediction tool.
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To gain deeper insight into the association of Stx2a, ShET1 and H4 flagellin with OMVs, we per-
formed OptiPrep density gradient fractionation of LB226692 OMVs and analysed the resulting frac-
tions for OmpA and the virulence proteins by immunoblot. OMVs were identified in fractions 1 to 7 
(Fig.  2b). The first six fractions also contained Stx2a and ShET1, which were absent from OmpA-free 
fractions 8 to 12 (Fig. 2b). Flagellin was identified in fractions 4 to 12; almost half (45%) of flagellin was 
present in OMV-containing fractions 4 to 7 (Fig. 2b), and was thus, like Stx2a and ShET1, presumably 
tightly associated with OMVs. The tight association of these virulence factors with OMVs was confirmed 
by dissociation assays. Treatment with salt (1 M NaCl), alkaline (0.1 M Na2CO3) or chaotropic reagent 
(0.8 M urea) did not release any of the virulence proteins from OMVs (Fig. 2c). This was only possible 
by treatment with 1% SDS, which completely disrupts OMV membranes (Fig.  2c). Altogether, these 
experiments demonstrated that LB226692 OMVs consist of several subpopulations, which differ by their 
virulence factors cargoes, in particular by the presence of flagellin (Fig. 2b,d). The distribution of OMVs, 
ShET1, and flagellin in OptiPrep gradient fractions of OMVs C227-11Φ cu was similar to that in OMVs 
LB226692, but Stx2a was absent. To investigate biological effects of the OMV-associated virulence factor 
cocktail on human IECs, we used in further experiments pools of the fractions 1 to 7 as purified OMVs. 
The amounts of the total protein, Stx2a, H4 flagellin and O104 LPS in the purified OMVs are shown in 
Supplementary Table S4.
Localisation of virulence factors within OMVs. Electron microscopy of purified LB226692 OMVs 
using anti-Stx2a and anti-H4 immunogold staining visualised Stx2a mostly inside OMVs and occasion-
ally in association with OMV membranes (Fig. 3a). Flagellin was mostly located on the exterior of OMVs 
(Fig. 3b). To verify these results, we subjected the OMVs to proteinase K (PK) digestion, in which pro-
teins inside OMVs are protected from degradation12. This approach allowed us to determine also the 
localisation of ShET1 (the antibody against which was not suitable for electron microscopy). The inability 
Figure 2. OMVs from E. coli O104:H4 outbreak strain contain a cocktail of virulence factors.  
(a) Distribution of virulence factors of the outbreak strain in OMVs and OMV-free supernatants. OMVs 
and OMV-free supernatants from strains LB226692 and C227-11Φ cu were analysed by immunoblot with 
antibodies against OmpA (an OMV marker) and the indicated virulence proteins (signals obtained from 
OMVs and OMV-free supernatants tested on the same membrane are separated by a vertical line).  
(b) Distribution of Stx2a, ShET1 and H4 flagellin in OptiPrep density gradient fractions of OMVs LB226692 
demonstrated by immunoblot. The numbers above the blots (from left to right) indicate the order of the 
fractions in which they were collected from top to bottom of ultracentrifugation tubes. The lanes designated 
OMV contain non-fractionated OMVs (positive control). (c) Dissociation assay. Pools of LB226692 OMV 
OptiPrep fractions 1 to 6 and 4 to 7, respectively, were incubated in HEPES buffer alone (control), or in 
HEPES buffer with the indicated chemicals. After ultracentrifugation, pellets (P; containing OMVs) and 
supernatants (S; containing proteins released from OMVs) were immunoblotted with anti-Stx2a or anti-
ShET1 (pool of fractions 1 to 6) or anti-H4 (pool of fractions 4 to 7) antibodies. Signals in panels (a–c) were 
visualised with Chemi Doc XRS imager, and quantified (in panels (a,b)) using Quantity One® software. 
Sizes of immunoreactive bands are shown on the right side (for Stx2a, ShET1, and AAF/I the size of the 
A subunit is provided). Crops of representative immunoblots are shown. Full immunoblots are shown in 
Supplementary Figures S5, S6, and S7. (d) Percentual distribution of OmpA, Stx2a, ShET1 and H4 flagellin 
in OptiPrep gradient fractions 1 to 7 as demonstrated by densitometric quantification of immunoblot signals 
shown in panel (b) using Quantity One® (the sum of signals of each virulence factor in fractions 1 to 7 was 
considered 100%).
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of PK to degrade Stx2a and ShET1 in intact OMVs indicated that these proteins are located intravesic-
ularly (Fig. 3c). In contrast, flagellin was degraded by PK, indicating that it is exposed on the exterior 
of OMVs (Fig. 3c). The PK protection assay thus corroborates the electron microscopic observations.
E. coli O104:H4 OMVs bind to human IECs and are internalised via dynamin-dependent endo-
cytosis. To determine whether LB226692 and C227-11Φ cu OMVs bind to and are internalised by 
IECs, the OMVs labelled with the fluorescent membrane dye 3,3 dioctadecyloxacarbocyanine perchlo-
rate (DiO) were incubated with cells and the kinetics of their uptake was monitored by flow cytome-
try. Internalised OMVs were distinguished from cell-bound, but non-internalised OMVs by quenching 
extracellular DiO-OMV fluorescence with trypan blue (TB)14. DiO-OMVs from each strain bound to 
and were internalised by each cell line in a time-dependent manner (Fig.  4a–c). Notably, the abilities 
of OMVs to bind and enter the cells substantially varied between the lines as indicated by the different 
mean fluorescence intensities after 24 h on Caco-2 (without TB ~ 65, with TB ~ 20), HCT-8 (without 
TB ~ 40, with TB ~ 12) and HT-29 cells (without TB ~ 20, with TB ~ 10) (Fig.  4a–c). However, despite 
these cell-specific variations, there were no significant differences in cellular binding and internalisation 
Figure 3. Localisation of Stx2a, ShET1 and H4 flagellin within OMVs. (a,b) Immunogold staining of 
ultrathin frozen sections of purified OMVs from strain LB226692 with (a) anti-Stx2a and (b) anti-H4 
antibody and Protein A Gold (10 nm). The images were acquired with a FEI-Tecnai 12 electron microscope. 
Bars are 100 nm. (c) Immunoblot analyses of proteinase K (PK)-untreated (PK− ) and PK-treated (PK+ ) 
OMVs LB226692 either intact (EDTA− ) or lysed with 0.1 M EDTA (EDTA+ ) with anti-Stx2a, anti-
ShET1, and anti-H4 flagellin antibodies. Signals were visualised with Chemi Doc XRS imager. Sizes of 
immunoreactive bands are shown on the right side. Crops of representative immunoblots are shown. Full 
immunoblots are shown in Supplementary Fig. S8.
www.nature.com/scientificreports/
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Figure 4. E. coli O104:H4 OMVs bind to human IECs and are internalised via dynamin-dependent 
endocytosis. (a–c) Kinetics of OMV binding and internalisation. Caco-2 (a) HCT-8 (b) and HT-29 cells  
(c) were incubated with DiO-labelled OMVs from strains LB226692 or C227-11Φ cu for 24 h and 
fluorescence was measured at the times indicated using FACScan flow cytometer before (total cell-
associated OMVs) and after trypan blue (TB) quenching (internalised OMVs). The data were analysed 
using CellQuestTM Pro software, expressed as geometric means of fluorescence intensities from 10,000 cells 
after subtraction of background fluorescence of cells without OMVs, and are presented as means ± standard 
deviations from three experiments. (d–g) CLSM of OMV uptake. Caco-2 (d) HCT-8 (e) and HT-29 (f) cells 
were incubated with OMVs from strains LB226692 or C227-11Φ cu for the times indicated. OMVs (green) 
were detected with anti-E. coli O104 LPS antibody and Alexa Fluor 488-conjugated goat anti-rabbit IgG, 
actin (red) with phalloidin-TRITC and nuclei (blue) with DRAQ5. (g) Control cells incubated for 24 h with 
OMV buffer instead of OMVs and stained as above. Pictures were taken using a laser-scanning microscope 
(LSM 510 META microscope, equipped with a Plan-Apochromat 63x/1.4 oil immersion objective). All 
three images were merged and confocal Z-stack projections are included in panels (d–f). The cross hairs 
show the position of the xy and yz planes. Scale bars are 10 μ m. (h–j) Effects of inhibitors of endocytosis 
on OMV uptake. LB226692 and C227-11Φ cu OMVs labelled with rhodamine isothiocyanate B-R18 were 
incubated for 6 h with Caco-2 (h), HCT-8 (i) and HT-29 (j) cells which had been pretreated (30 min) with 
the indicated inhibitors or remained untreated. After solubilisation of cells with Triton-X-100 fluorescence 
was measured (FLUOstar OPTIMA) and OMV uptake (reflected by the fluorescence intensity) in the 
presence of each inhibitor was expressed as the percentage of OMV uptake by control, inhibitor-untreated 
cells (100%). **P < 0.01, and ***P < 0.001 compared to inhibitor-untreated cells (one-way ANOVA). Data are 
means ± standard deviations from three independent experiments.
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of Stx2a-containing (LB226692) and Stx2a-lacking (C227-11Φ cu) OMVs (Fig.  4a–c), indicating a 
Stx2a-independent mechanisms of OMV binding and internalisation.
The time-dependent cellular uptake of OMVs was confirmed by confocal laser scanning microscopy 
(CLSM). After 15 min, single OMVs were associated with cell membranes (Fig.  4d–f, panels 15 min). 
After 6 h and 24 h, the amounts of cell-associated OMVs increased; OMVs were internalised and accu-
mulated in perinuclear regions (Fig. 4d–f, panels 6 h and 24 h). No OMV signals were observed in control 
cells incubated for 24 h with OMV buffer instead of OMVs (Fig. 4g).
To gain insight into the mechanism of the OMV uptake, we analysed effects of inhibitors of endocy-
tosis on this process. Dynasore, an inhibitor of dynamin-115, inhibited the OMV uptake to ≤ 25% of their 
uptake by control, inhibitor-untreated cells (P < 0.001) (Fig.  4h–j). Significant inhibition (to less than 
70% of control in each cell line) (P < 0.01) was also caused by chlorpromazine and hypertonic (0.45 M) 
sucrose, respectively (Fig. 4h–j), which both inhibit clathrin-mediated endocytosis16,17. In contrast, fili-
pin and nystatin, which disrupt lipid rafts and caveolae18,19, and inhibitors of macropinocytosis includ-
ing amiloride and cytochalasin D20 had no effects on OMV uptake in any cell line (Fig.  4h–j). These 
experiments indicated that LB226692 and C227-11Φ cu OMVs are internalised via dynamin-dependent 
endocytosis, which might be clathrin-mediated.
OMVs deliver Stx2a, ShET1 and flagellin intracellularly and are toxic to human IECs. Presence 
of OMVs and the OMV-associated virulence factors (Stx2a, ShET1 and H4 flagellin) in cell lysates after 
6 h of incubation of cells with OMVs was demonstrated using immunoblot (Fig.  5a). The intracellular 
localisation of the virulence factors was confirmed by CLSM which demonstrated that all of them colo-
calised with OMVs (Fig. 5b–d). Neither OMVs nor any of the virulence factors were detected in control 
cells exposed to OMV buffer instead of OMVs (Supplementary Fig. S1).
To determine if the OMV-delivered Stx2a is biologically active, we tested LB226692 and C227-11Φ cu 
OMVs for their toxicities towards IECs and highly Stx-sensitive Vero cells21 which also internalised the 
OMVs (Fig. 5a). LB226692 OMVs were toxic to each cell line (Fig. 5e). Their cytotoxicity titres were sim-
ilar to those of the supernatant of a prototypic EHEC O157:H7 strain EDL933 used as a positive control, 
and, in accordance with low sensitivity of human IECs to Stx22,23, they were significantly lower on IECs 
than on Vero cells (Supplementary Table S5). Preincubation of OMVs with Stx2a-neutralising antibody24 
did not reduce their cytotoxicity titres (Supplementary Table S5). This confirmed that intravesicular Stx2a 
(which is not accessible to the antibody) and not free toxin (neutralisable by the antibody24), which might 
have accidentally contaminated OMV surface during their handling, is responsible for the cytotoxicity. 
Stx2a-negative C227-11Φ cu OMVs were non-toxic (Fig.  5e, Supplementary Table S5), confirming that 
the cytotoxicity elicited by OMVs LB226692 was mediated by Stx2a.
OMV-associated Stx2a causes apoptosis of human IECs via caspase-9 and caspase-3 activa-
tion. Next, we investigated the mechanism of cell death caused by LB226692 OMVs by analysing IECs 
exposed to purified OMVs (containing 580 ng/ml of Stx2a) for apoptosis and necrosis by Cell Death 
Detection ELISA. The LB226692 OMVs induced apoptosis in each cell line, which was evident after 24 h 
(HCT-8 and HT-29) or 48 h (Caco-2) (Fig. 6a). They caused no considerable necrosis up to 48 h (Fig. 6b). 
OMVs C227-11Φ cu caused neither apoptosis nor necrosis (Fig. 6a,b) indicating that Stx2a is the major 
OMV component responsible for the apoptotic cell death. Accordingly, purified free Stx2a (580 ng/ml; 
used as a control) caused apoptosis in a similar extent as did the same dose of LB226692 OMV-associated 
Stx2a (Fig. 6a).
To confirm the apoptotic effect of LB226692 OMVs and to determine the minimum amounts of 
OMV-associated and free Stx2a capable of triggering apoptosis, we exposed IECs to decreasing doses 
of the OMVs and purified Stx2a and quantified cells with hypodiploid nuclei by flow cytometry. Both 
LB226692 OMVs and free Stx2a elicited a significant and dose-dependent formation of cells with hypo-
diploid nuclei in the range of toxin doses between 580 ng/ml and 29 ng/ml in Caco-2 cells, and 580 ng/
ml and 14.5 ng/ml in HCT-8 and HT-29 cells (Fig. 6c). Altogether, these experiments demonstrated that 
OMV-associated Stx2a causes apoptosis of IECs as efficiently as free Stx2a.
Since the formation of hypodiploid nuclei induced by OMVs LB226692 was significantly reduced by 
preincubation of cells with a pan-caspase inhibitor z-VAD-fmk (Fig.  6d), we next investigated which 
caspases are involved in apoptosis caused by these OMVs. Caspase-9 and caspase-3 (Fig.  6e), but not 
caspases-2, -6 and -8 (Supplementary Fig. S2), were activated in each cell line after 48 h of incubation 
with LB226692 OMVs. The caspase-9 and caspase-3 activation was inhibited by cell pretreatment with 
the specific caspase inhibitor (z-LEHD-fmk and z-DEVD-fmk, respectively) (Fig. 6e). No activation of 
caspase-9 or caspase-3 was detected in cells treated with C227-11Φ cu OMVs (Fig. 6e). Thus, Stx2a is the 
key OMV component triggering the caspase activation and subsequent apoptosis.
Time-lapse digital holographic microscopy (DHM). Time-lapse DHM of living HCT-8 cells was 
used to monitor in detail cellular changes caused by LB226692 OMVs. Control cells displayed regular 
cell divisions (Supplementary Video 1) resulting in an increase of the cell-covered area, cell density and 
cell layer thickness between 0 and 48 h (Fig. 7a, left panel). Dry mass of the control cell patch increased 
3-fold within 48 h, whereas cells treated with LB226692 OMVs showed no divisions (Supplementary 
Video 1) and no gain of dry mass (Fig. 7b). Moreover, single OMV-treated cells moved out of the cell 
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Figure 5. E. coli O104:H4 OMVs deliver OMV-associated virulence factors intracellularly and cause 
cytotoxicity via Stx2a. (a) Cells were incubated for 6 h with OMVs from strains LB226692 or C227-11Φ cu 
or without OMVs (control). Cell lysates were analysed by immunoblot for OMVs (anti-OmpA), Stx2a, 
ShET1, H4 flagellin, and actin (loading control); signals were visualised with Chemi Doc XRS imager. Sizes 
of immunoreactive bands are shown on the right side. Crops of representative immunoblots are shown. 
Full immunoblots are shown in Supplementary Fig. S9. (b–d) Cells were incubated for 6 h with OMVs 
LB226692 or C227-11Φ cu. OMVs were stained with mouse anti-E. coli LPS antibody and Alexa Fluor 
488-conjugated goat anti-mouse IgG (green), Stx2a, H4 flagellin (Fla) and ShET1 with their respective 
antibodies and Cy3-conjugated goat anti-rabbit IgG (red), and nuclei with DRAQ5 (blue). Pictures were 
taken using a laser-scanning microscope (LSM 510 META microscope, equipped with a Plan-Apochromat 
63x/1.4 oil immersion objective). All three fluorescence images were merged (left panels; colocalised red 
and green signals appear in yellow) and single fluorescence channels are shown in the right panels. Pictures 
consisted of one optical section of a z-series with a pinhole of 1 airy unit. Scale bars are 10 μ m. (e) Cells 
were incubated for 72 h with LB226692 or C227-11Φ cu OMVs or remained untreated (control); cells were 
stained with crystal violet, analysed microscopically (Axio Imager.A1) and photographed (AxioCam CCD 
camera). For LB226692 OMVs photomicrographs of cells displaying ~50% cytotoxicities are shown. Scale 
bars are 20 μ m.
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Figure 6. OMV-associated Stx2a causes apoptosis of human IECs via caspase-9 and caspase-3 activation. 
(a,b) Caco-2, HCT-8, and HT-29 cells were incubated with OMVs LB226692 (containing 580 ng/ml of 
Stx2a) or purified Stx2a (580 ng/ml; control) or OMVs C227-11Φ cu or OMV buffer for 24 h and 48 h or 
remained untreated; cells were analysed for apoptosis (a) and necrosis (b) by Cell Death Detection ELISA. 
Enrichment factors were calculated by dividing OD405 absorbance values of sample-treated cells with those 
of untreated cells; **P < 0.01 compared to OMV buffer (one-way ANOVA). (c) Cells were incubated (48 h) 
with decreasing doses of OMVs LB226692 (containing the indicated amounts of Stx2a) or with the same 
doses of purified Stx2a, or with OMVs C227-11Φ cu (Stx2a-negative) or 1 μ M staurosporin (Stauro; positive 
control) or remained untreated (control). Cells with hypodiploid nuclei were quantified by flow cytometry 
(FACScalibur) after propidium iodide staining (red channel, 570 nm). Data from 10,000 nuclei were analysed 
by CellQuestTM Pro software. **P < 0.01, and *P < 0.05 compared to untreated cells (one-way ANOVA).  
(d) Cells were incubated (48 h) with OMVs LB226692 (containing 580 ng/ml of Stx2a) or 1 μ M staurosporin 
(Stauro; positive control) without and after cell pre-treatment with pan-caspase inhibitor z-VAD-fmk. 
Apoptotic cells were quantified as in c; **P < 0.01, and *P < 0.05 for comparison between non-pretreated and 
z-VAD-pretreated cells (unpaired Student´s t test). (e) Cells were incubated (48 h) with OMVs LB226692 
(containing 580 ng/ml of Stx2a) or OMVs C227-11Φ cu (Stx2a-negative) or remained untreated. Caspase-9 
and caspase-3 activities in cell lysates were determined using colorimetric substrates (LEHD-pNA and 
DEVD-pNA, respectively); the colour intensity, which is proportional to the level of caspase enzymatic 
activity, was measured spectrophotometrically at 405 nm (FLUOstar OPTIMA reader). The caspase activity 
in OMV-treated cells was expressed as a fold-increase of that in untreated control cells (set up as 1). 
Inhibitors of caspase-9 (z-LEHD-fmk) or caspase-3 (z-DEVD-fmk) were added to cells 30 min before OMVs; 
*P < 0.05 compared to untreated cells (one-way ANOVA). Data in all panels are shown as means ± standard 
deviations from three independent experiments.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 5:13252 | DOi: 10.1038/srep13252
Figure 7. Monitoring of OMV-mediated cellular changes by DHM. (a) Segmented (green outlines) 
quantitative DHM phase contrast images of HCT-8 cells after 0 h, 24 h, and 48 h of incubation with cell 
culture medium (control) or OMVs LB226692 (containing 580 ng/ml of Stx2a). Scale bars are 10 μ m.  
(b) Time-dependent gain of cellular dry mass calculated based on the growth area and the mean phase 
contrast (normalized to the respective dry mass at t0). Quantitative phase images were calculated from 
digital off-axis holograms (acquired by custom built C+ + software) utilizing custom built software 
developed in the PV-Wave 9.5 programming environment (www.roguewave.com) and analysed for cell 
covered area and average phase contrast by image segmentation with the cell profiler software (www.
cellprofiler.org) from which the cellular dry mass was calculated.
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aggregate and five of eight monitored cells underwent apoptosis (after 22 h, 29 h, 37 h, 40 h, and 47.5 h) 
(Supplementary Video 1). This led to the disintegration of the cell patch (Fig. 7a, right panel, 48 h). DHM 
thus confirmed the OMV LB226692-mediated apoptosis of HCT-8 cells.
E. coli O104:H4 OMVs induce interleukin (IL)-8 secretion by human IECs. We next investi-
gated purified OMVs from strains LB226692 and C227-11Φ cu for their abilities to induce production of 
proinflammatory cytokines by human IECs and identified the OMV components involved in this effect. 
Of 12 cytokines tested (see Methods), IL-8 was produced by all cell lines after exposure to each OMV 
preparation. The IL-8 secretion rapidly increased between 15 min and 1 to 3 h, when it either reached 
a plateau (HCT-8) or further increased up to 24 h (Caco-2, HT-29 cells) (Fig.  8a). The IL-8 amounts 
elicited by OMVs C227-11Φ cu (containing 80 ng/ml of flagellin and 950 ng/ml of LPS) were usually 
higher, though not always significantly, than those induced by LB226692 OMVs (containing the same 
amounts of flagellin and LPS plus 58 ng/ml of Stx2a) (Fig. 8a). This suggested that Stx2a is dispensable 
for OMV-mediated IL-8 secretion. This was further supported by the very low IL-8 amounts elicited after 
24 h by purified Stx2a (58 ng/ml) from Caco-2 (5 pg/ml), HCT-8 (69 pg/ml), and HT-29 (42 pg/ml) cells.
To explore the roles of H4 flagellin and O104 LPS in the OMV-induced IL-8 secretion, we first com-
pared the IL-8 responses elicited after 24 h by OMVs and by the same amounts of isolated flagellin and 
O104 LPS (80 ng/ml and 950 ng/ml, respectively). The IL-8 response elicited by isolated flagellin was sim-
ilar to (HCT-8 and HT-29) or greater than (Caco-2) those induced by LB226692 and C227-11Φ cu OMVs 
(Fig. 8b, columns without antibodies). The IL-8 response induced by isolated O104 LPS was significantly 
lower than that elicited by each OMV preparation in each cell line (Fig. 8c, columns without polymyxin 
B). Second, we analysed the impact of inhibiting the flagellin-mediated and LPS-mediated signalling, 
respectively, which underlies IL-8 secretion25,26 on the OMV abilities to induce IL-8 response. To this end, 
we preincubated OMVs (or isolated H4 flagellin as a control) with anti-H4 antibody and/or cells with 
anti-Toll-like receptor (TLR) 5 antibody to inhibit the flagellin-TLR5 signalling. Alternatively, we prein-
cubated OMVs (or isolated O104 LPS as a control) with polymyxin B, which inhibits LPS recognition by 
the TLR4/MD-2 complex27,28. TLR5, as well as TLR4 and MD-2, were expressed by all cell lines (Fig. 8e). 
Both anti-H4 and anti-TLR5 antibody significantly reduced the OMV-induced and flagellin-induced 
IL-8 responses; a combined use of both antibodies almost completely inhibited IL-8 secretion (Fig. 8b). 
Preimmune sera had no inhibitory effects (Supplementary Fig. S3). Moreover, polymyxin B also sig-
nificantly reduced the IL-8 amounts induced by OMVs and O104 LPS (Fig. 8c). Altogether, these data 
indicate that both H4 flagellin and O104 LPS contribute to the OMV O104:H4-induced IL-8 secretion 
by human IECs, and that TLR5- and TLR4/MD-2-mediated signalling, respectively, is involved in this 
process. The OMV-induced IL-8 response was dose-dependent in each cell line; the lowest OMV doses 
which elicited a measurable IL-8 secretion after 24 h contained 1 ng/ml of H4 flagellin and 11.88 ng/ml 
of O104 LPS (Fig. 8d).
Discussion
The highly virulent E. coli O104:H4 hybrid, which caused the largest and most devastating HUS out-
break in history1, releases a cocktail of its virulence factors via OMVs. The OMVs bind to and are 
internalised by human IECs, deliver the OMV-associated virulence factors intracellularly, and induce 
caspase-9-mediated apoptosis and an inflammatory response, in particular secretion of IL-8. Stx2a is the 
key OMV component responsible for the cytotoxicity, whereas flagellin and LPS are the major factors 
involved in IL-8 secretion.
The Stx2a secretion via OMVs described here and reported previously for Stx2a of EHEC O157:H729 
demonstrates that besides release of free Stx2a from bacteria via stx-phage-mediated lysis30, the OMVs 
represent a novel efficient mechanism for bacterial toxin release. Importantly, we show for the first time 
that OMV-associated Stx2a is taken up by the host cells and causes cytotoxicity as efficiently as free 
Stx2a. In contrast to free Stx2a, which requires the presence of globotriaosylceramide (Gb3) receptor for 
its cellular binding, internalisation and exerting cytotoxicity31, the Stx2a-containing OMVs bind to and 
are internalised by IECs independently of Stx2a and thus, plausibly, independently of Gb3. This is sup-
ported by: (i) similar rates of cellular binding and internalisation of Stx2a-containing and Stx2a-lacking 
OMVs; (ii) intravesicular localisation of Stx2a, which makes the OMV-associated toxin inaccessible for 
the receptor binding; and (iii) the inability of filipin and nystatin, which disrupt lipid rafts18,19, the site 
of Gb3 clustering in Stx-sensitive cells31,32 including IECs used in our study32,33, to inhibit OMV cellular 
uptake.
By its dispensability for OMV cellular binding and internalisation, the OMV-associated Stx2a essen-
tially differs from other AB5 toxins, namely OMV-associated heat-labile enterotoxin (LT) of enterotox-
igenic E. coli34 and cholera toxin35, each of which mediates cellular binding and internalisation of the 
toxin-containing OMVs via interaction with its specific receptor GM134,35. In contrast, the Stx2a-carrying 
OMVs serve as vehicles for toxin-independent Stx2a intracellular delivery. Thus, the association of a 
subset of Stx2a secreted by the E. coli O104:H4 outbreak strain and by classical EHEC29 with OMVs 
suggests a new, hitherto unappreciated, mechanism for a putative toxin´s interaction with cells which 
do not express Gb3. The roles of Stx2a-containing OMVs in interactions of the toxin with Gb3-negative 
human colon epithelium33,36, specifically in the toxin delivery into colonocytes where it was observed 
in EHEC-infected patients37, and in translocation of the toxin across the intestinal barrier37,38, which is 
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critical for its systemic spread into the kidneys during HUS39, warrant further investigations. Interestingly, 
the Stx2a delivery into human intestinal epithelial cells via bacterial OMVs parallels the recently reported 
systemic transfer of Stx2a and its delivery into glomerular endothelial cells, the major toxin targets dur-
ing HUS, via microvesicles derived from human blood cells40.
In contrast to its dispensability for OMV cellular binding and internalisation, Stx2a is the key com-
ponent of E. coli O104:H4 OMVs responsible for their apoptotic potential. Induction of apoptosis by 
Figure 8. E. coli O104:H4 OMVs induce IL-8 secretion by human IECs via flagellin and LPS. (a) Caco-
2, HCT-8, and HT-29 cells were incubated with OMVs LB226692 (containing 58 ng/ml of Stx2a, 80 ng/
ml of flagellin, and 950 ng/ml of LPS) or OMVs C227-11Φ cu (containing 80 ng/ml of flagellin and 950 ng/
ml of LPS) for 15 min, 1 h, 3 h, and 24 h; IL-8 in cell culture supernatants was quantified by a Single-
Analyte IL-8 ELISArray; *P < 0.05 (unpaired Student’s t test) for comparison between OMVs LB226692 
and C227-11Φ cu. (b) Cells were exposed for 24 h to: OMVs or isolated H4 flagellin (80 ng/ml) in the 
absence of antibodies; OMVs or flagellin which had been preincubated with anti-H4 antibody; OMVs or 
flagellin after cell preincubation with anti-TLR5 antibody; OMVs or flagellin which had been preincubated 
with anti-H4 antibody after cell preincubation with anti-TLR5 antibody. IL-8 secretion was quantified as 
above; **P < 0.01 or ***P < 0.001 (one-way ANOVA) for comparison between each OMV preparation or 
flagellin without and after preincubation with each respective antibody combination. (c) IL-8 secretion was 
quantified in cells incubated for 24 h with OMVs or isolated O104 LPS (950 ng/ml) without polymyxin 
B (polyB-) or with OMVs or LPS which had been preincubated with polymyxin B (polyB+ ); *P < 0.05 
(one-way ANOVA) for comparison between each OMV preparation or LPS without and after polymyxin B 
preincubation; **P < 0.01 (one-way ANOVA) for comparison between each OMV preparation and isolated 
O104 LPS. (d) Cells were incubated for 24 h with 10-fold dilutions of OMVs LB226692 or C227-11Φ cu 
containing the indicated amounts of flagellin and LPS; IL-8 secretion was quantified as above. Data in panels 
(a–d) are means ± standard deviations from three independent experiments. (e) Detection of TLR5, TLR4 
and MD-2 in lysates of Caco-2, HCT-8, and HT-29 cells using immunoblot. Signals were visualised with 
Chemi Doc XRS imager. Sizes of immunoreactive bands are shown on the right side. Crops of representative 
immunoblots are shown. Full immunoblots are shown in Supplementary Fig. S10.
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OMV-associated Stx2a is in accordance with the ability of free, purified Stx2a to cause apoptosis of 
IECs (Fig. 6a,c) and other cell types (reviewed in41), as well as with reports of Stx-attributable apoptosis 
of the renal tubular and endothelial cells in patients with HUS caused by EHEC42 and E. coli O104:H4 
outbreak strain43. Contributions of OMV-associated Stx2a to the apoptosis of the colonic and caecal 
epithelium and subsequent diarrhoea reported in infant rabbits infected with the outbreak strain7 need 
to be determined.
The role of flagellin in the virulence of E. coli O104:H4 has not been investigated, but flagellin contrib-
utes to the virulence of both EHEC and EAEC by upregulating secretion of proinflammatory cytokines 
by intestinal epithelial cells25,36,44–47. In EHEC, this process facilitates Stx translocation across the intes-
tinal epithelium, which is the prerequisite for the toxin´s entry into the blood stream and reaching its 
target organs39. We demonstrate that OMVs released by the E. coli O104:H4 outbreak strain induce IL-8 
secretion by IECs and that H4 flagellin and O104 LPS are essential OMV components involved in this 
process. This is in agreement with observations reported for OMVs from Pseudomonas aeruginosa28. We 
also show that the TLR5- and TLR4/MD-2-mediated signalling underlies the IL-8 response elicited by 
OMV-associated H4 flagellin and O104 LPS, respectively.
Notably, Stx2a plays, based on our data, little or no role in OMV-mediated inflammatory responses 
by IECs as indicated by similar IL-8 amounts elicited by OMVs with and without Stx2a (Fig. 8a) and by 
minimal IL-8 amounts elicited by purified Stx2a. Our findings for OMVs are in agreement with stud-
ies using EHEC bacteria, in which flagellin, and not Stx, is the major bacterial factor that upregulates 
proinflammatory cytokine production by cultured IECs (HCT-8, Caco-2)44,45. In other studies, however, 
purified Stx1a and Stx2a induced IL-8 production by IECs either alone48 or in synergy with flagellin46. 
These variant observations may result from different experimental conditions. We could not confirm, 
using OMVs from strain C227-11Φ cu and nonpolarised IECs, the previous observation on polarized 
T84 cells8 that the loss of the Stx2a-encoding phage by the outbreak strain significantly reduced the IL-8 
response. However, a study using human colonic xenografts indicates that flagellin and not Stx2a is the 
main inducer of proinflammatory cytokine production by human colonic epithelium in vivo36.
In summary, OMVs represent yet unrecognized powerful tools of the E. coli O104:H4 outbreak strain 
for the delivery of its virulence factors into IECs and causing cell injury and inflammatory responses. Our 
data have also implication for the use of OMVs as potential vaccine candidates to prevent disease caused 
by E. coli O104:H4. The mechanisms of intracellular trafficking of OMVs and the associated virulence 
factors, as well as the signalling pathways underlying apoptosis and IL-8 secretion induced by OMVs 
clearly warrant further investigations.
Methods
Ethics statement. This study was performed in accordance with guidelines approved by the Ethical 
Committee of the Medical Faculty of the University of Muenster and of the Aerztekammer Westfalen-
Lippe. Our institutional review board waived the need for written informed consent from the participants.
Strains. Strain LB226692 was isolated during the 2011 outbreak from a patient with HUS and exten-
sively characterised3. C227-11Φ cu is a stx2a-phage-cured derivative of the outbreak strain5. The high 
similarity (“isogenicity”) of both strains was confirmed by whole genome sequencing (see Supplementary 
Methods and Supplementary Table S6). EHEC O157:H7 strain EDL933 was isolated from hamburgers 
identified as the source of early EHEC outbreaks49.
Antibodies. Anti-E. coli O104 LPS and H4 antibodies were produced50 in rabbits using reference strains 
H519 (O104:K−:H12) and U9-41 (O2:K1:H4), respectively. Anti-Stx2a24 and anti-OmpA51 antibodies were 
described. Rabbit antibodies against SigA, Pic, SepA, and ShET1 A subunit were produced by Aptum 
Biologics Ltd. (Southampton, UK), and antibody against AAF/I A subunit by Davids Biotechnologie 
(Regensburg, Germany). Commercial antibodies were: anti-actin (Santa Cruz Biotechnology); anti-E. coli 
LPS antibody (Abcam); anti-TLR5 neutralising antibody and the rat IgG control (InvivoGen); anti-TLR5 
detection antibody (Abcam); anti-TLR4 (Invitrogen); anti-MD-2 (Novus Biological); Alexa Fluor 
488-conjugated goat anti-rabbit or anti-mouse IgG (Molecular Probes); Cy3-conjugated goat anti-rabbit 
IgG; and alkaline-phosphatase-conjugated goat anti-rabbit IgG (Dianova).
Preparation of OMVs and OMV-free supernatants. OMVs were isolated from 500 ml of LB cul-
tures14 and resuspended in 1 ml of 20 mM TRIS-HCl (pH 8.0). OMV-free supernatants after ultracen-
trifugation were 500-fold concentrated using Vivaspin 20 concentrators, molecular weight cut-off 3,000 
or 10,000 (GE Healthcare).
Kinetics of OMV production. Kinetics of OMV production was determined as described14. Briefly, 
samples of overnight LB broth cultures were taken each hour between 1 h and 12 h, after 16 h and after 
24 h, and OMVs and OMV-free supernatants were prepared as above. Aliquots (~5 μ g of protein/lane) 
were separated by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and imunob-
lotted14 with anti-OmpA antibody (an OMV marker). Signals were visualised with Chemi Doc XRS 
imager (BioRad) and quantified densitometrically (Quantity One® ). Bacterial growth was monitored by 
measuring optical density at 600 nm.
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Protein composition of OMVs. OptiPrep gradient purified OMVs (5 μ g of protein/lane) were sep-
arated by SDS-PAGE and proteins were visualised with ProteoSilver™ Plus Silver Stain Kit (Sigma). 
Proteins were identified in collaboration with Alphalyse (Odense, Denmark) by tryptic digestion of total 
proteins from the gel followed by Q-TOF nano-LC-MS/MS. The MS/MS spectra were used for Mascot 
(www.matrixscience.com/) searching in the NBCI database. Protein subcellular localisations were deter-
mined with PsortB (www.psort.org/psortb/).
Detection of OMV-associated DNA and virulence genes. Presence of DNA in OMVs (intact, 
either DNase-untreated or DNase-treated, or lysed after the DNase treatment14) was analysed with 
Quant-iT PicoGreen dsDNA Assay (Molecular Probes)14. PCRs for virulence genes detection (listed in 
Supplementary Table S2) were performed with published primers2,52,53 in 25 μ l volume containing 2.5 μ l 
of OMVs (either non-fractionated, DNase-untreated or DNase-treated14, or pools of OptiPrep fractions 
1 to 7). DNA from strains LB226692 and C227-11Φ cu was a positive, and DNA from E. coli K-12 C600 
a negative control.
Analyses of OMVs and OMV-free supernatants for virulence factors. OMVs and OMV-free 
supernatants (~5 μ g of protein/lane) were separated by SDS-PAGE and immunoblotted with antibodies 
against OmpA, Stx2a, ShET1, Pic, SigA, SepA, AAF/I A subunit and H4 flagellin. After densitometric 
quantification of signals, the percentages of Stx2a and H4 flagellin associated with OMVs and present in 
OMV-free supernatants were calculated.
OMV fractionation, dissociation assay, proteinase K (PK) assay. OMVs were fractionated by 
density gradient ultracentrifugation with OptiPrep (Sigma) as described14. Gradient fractions removed 
sequentially from the top were immunoblotted with anti-OmpA, anti-Stx2a, anti-ShET1 and anti-H4 
antibody. Dissociation assay was performed with pools of LB226692 OMV fractions 1 to 6 and 4 to 7, 
respectively (~5 μ g of OMV protein) as described14 to determine if Stx2a, H4 flagellin and ShET1 can be 
released from OMVs by chemicals (1 M NaCl, 0.1 M Na2CO3, 0.8 M urea, 1% SDS). In the PK assay12, 
purified LB226692 OMVs (20 μ g of protein) either intact or lysed (2 h, 37 °C) with 0.1 M EDTA were 
treated with proteinase K (Sigma) (100 μ g/ml, 30 min). Aliquots (10 μ l) were separated using SDS-PAGE 
and immunoblotted with anti-Stx2a, anti-ShET1 and anti-H4 antibody.
Purified LPS, flagellin and Stx2a. Purified O104 LPS (1 mg/ml) was prepared by Micromun 
(Greifswald, Germany). H4 flagellin was isolated essentially according to Steiner et al.47. Coomassie 
blue-stained SDS-PAGE revealed a single band of ~40 kDa which reacted with anti-H4 antibody 
(Supplementary Fig. S4). Stx2a was purified as described54. Protein concentration in purified flagellin 
and Stx2a was determined with Roti-Nanoquant (Roth).
Concentrations of total protein, virulence proteins and LPS in purified OMVs. Protein con-
centration was determined with Roti-Nanoquant. Stx2a and flagellin concentrations were determined by 
densitometric comparison of signals produced by 10 μ l of OMVs and 10 μ l of serial dilutions of purified 
Stx2a (protein concentration 2.8 mg/ml) and isolated H4 flagellin (protein concentration 640 μ g/ml) used 
to generate calibration curves. OMV LPS content was determined with LAL Chromogenic Endotoxin 
Quantitation Kit (Thermo Fisher Scientific).
Cell cultures. Caco-2 and HT-29 (German collection of microorganisms and cell cultures, ACC 169 
and ACC 299, respectively), and HCT-8 (ATCC CCL-244) were cultured in Quantum 286 epithelial 
medium (GE Healthcare). Vero-B4 cells (ACC-33) were grown in OptiPRO SFM medium (Gibco). The 
passages used were: Caco-2, 21 to 32; HCT-8, 8 to 21; HT-29, 16 to 20; Vero, 15 to 19.
Electron microscopy. Electron microscopy of ultrathin sections of LB226692 LB agar culture or 
purified OMVs was performed14 using anti-E. coli O104 LPS (culture sections) or anti-Stx2a or anti-H4 
(OMVs) antibody and Protein A Gold (gold particles 10 nm). The samples were analysed at 80 kV on a 
FEI-Tecnai 12 electron microscope and photographed (Ditabis imaging plates).
OMV association with intestinal epithelial cells. Flow cytometric analysis of OMV cellular bind-
ing and internalisation was performed with DiO (Molecular Probes)-labelled OMVs as described14. 
For confocal laser scanning microscopy (CLSM), cells were incubated with OMVs (~50 μ g of protein) 
or OMV buffer for 15 min to 24 h and stained with anti-E. coli O104 LPS antibody and Alexa Fluor 
488-conjugated goat anti-rabbit IgG. Actin was counterstained with phalloidin tetramethyl rhodamine 
(phalloidin-TRITC) (Sigma) and nuclei with DRAQ5 (Cell Signalling). Preparations were analysed with 
a confocal laser-scanning microscope (LSM 510 META microscope, equipped with a Plan-Apochromat 
63x/1.4 oil immersion objective; Carl Zeiss).
Effects of inhibitors of endocytosis on OMV uptake were determined as described14 except that in 
addition to dynasore (80 μ M), chlorpromazine (15 μ g/ml), and filipin (10 μ g/ml), also 0.45 M sucrose, 
nystatin (50 μ g/ml), cytochalasin D (1 μ g/ml) and amiloride (10 mM) (Sigma) were used. Cells (untreated 
or inhibitor-pretreated for 30 min at 37 °C) were incubated with rhodamine isothiocyanate B-R18-labelled 
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OMVs14 (~50 μ g of OMV protein) for 6 h. After washing and cell permeabilisation with 1% Triton-X-100 
(3 min) fluorescence was measured (FLUOstar OPTIMA; BMG Labtech) and normalised to fluorescence 
of labelled OMVs incubated without cells. OMV uptake in the presence of each inhibitor was expressed 
as the percentage of OMV uptake by inhibitor-untreated cells.
OMV-mediated intracellular delivery of virulence factors. Cells were incubated (6 h) with puri-
fied OMVs (50 μ g of protein) or without OMVs, washed and lysed. After heating (10 min, 99 °C) cell 
lysates were centrifuged (16,900 × g, 15 min, 4 °C) and supernatants (cytoplasmic proteins; 50 μ g/lane) 
were SDS-PAGE-separated and immunoblotted14 with anti-OmpA, anti-Stx2a, anti-ShET1, anti-H4 or 
anti-actin antibody. For CLSM, cells were incubated (6 h) with OMVs (~50 μ g of protein) or OMV 
buffer. OMVs were stained with anti-E. coli LPS mouse antibody and Alexa Fluor 488-conjugated goat 
anti-mouse IgG, Stx2a, flagellin, and ShET1 with their respective antibodies and Cy3-conjugated goat 
anti-rabbit IgG, and nuclei with DRAQ5. Preparations were analysed with a confocal laser-scanning 
microscope as above.
Cytotoxicity assay. Cell monolayers were incubated with two-fold dilutions of purified OMVs 
LB226692 (4.7 μ g/ml to 1.15 ng/ml of protein containing 580 ng/ml to 141.5 pg/ml of Stx2a) or OMVs 
C227-11Φ cu (the same amounts of protein) or supernatant of EHEC O157:H7 strain EDL933 (positive 
control) for 72 h. To neutralise free Stx2a that might have contaminated OMVs during their handling, 
LB226692 OMVs were preincubated (1 h, 37 °C) with 40 μ g/ml of anti-Stx2a antibody24 before adding 
to cells. After removing medium with detached cells, remnant cells were stained (0.13% crystal violet), 
visualised (Axio Imager.A1, Zeiss), and cell detachment was quantified by measuring absorbance (OD570) 
of crystal violet eluted with ethanol54. Cytotoxicity titres were expressed as reciprocals of sample dilutions 
that killed 50% cells.
Mechanism of OMV-mediated cell death and caspase activation. The Cell Death Detection 
ELISAPLUS (Roche) was performed as described54 using cells incubated for 24 or 48 h with purified OMVs 
LB226692 (4.7 μ g/ml of protein containing 580 ng/ml of Stx2a) or C227-11Φ cu (4.7 μ g/ml of protein) or 
purified Stx2a (580 ng/ml) or OMV buffer. To identify the minimum apoptotic dose of OMV-associated 
and free Stx2a, cells were incubated (48 h) with LB226692 OMVs or purified Stx2a containing 580 ng/ml 
to 3.625 ng/ml of Stx2a. Apoptosis was quantified by flow cytometric detection of hypodiploid nuclei as 
described55,56. Staurosporin (1 μ M) (Sigma) was a positive, and untreated cells a negative control.
Activities of caspase-2, -3, -6, -8, and -9 in lysates of cells treated (48 h) with purified OMVs LB226692 
(4.7 μ g/ml of protein containing 580 ng/ml of Stx2a) or the corresponding amount of OMVs C227-11Φ cu 
protein were assayed with the Caspase Colorimetric Protease Assay Sampler Kit (Invitrogen). The caspase 
activities in OMV-treated cells were expressed as a fold-increase of their activities in untreated cells. 
If required, cells were pretreated (30 min) with 50 μ M pan-caspase inhibitor z-VAD-fmk or caspase-9 
(z-LEHD-fmk) or caspase-3 (z-DEVD-fmk) inhibitor (R & D Systems).
Digital holographic microscopy (DHM). DHM of HCT-8 cells exposed to LB226692 OMVs 
(4.7 μ g/ml of protein containing 580 ng/ml of Stx2a) or culture medium was performed using an 
incubator-integrated microscope (iMIC, Till Photonics, Gräfelfing, Germany) with a DHM module 
(engineered at the Center for Biomedical Optics and Photonics, University of Muenster, Germany)57,58. 
Digital holograms of the cells were recorded continuously every 3 min for 48 h by custom built C+ + 
software and reconstructed57,58. To analyse cellular growth and morphological changes, the cell covered 
area and the cell induced average phase contrast were determined by image segmentation using the cell 
profiler software (www.cellprofiler.org) from which the cellular dry mass was calculated57.
OMV-induced cytokine production. Presence of 12 cytokines (IL-1α , IL-1β , IL-2, IL-4, IL-6, 
IL-8, IL-10, IL-12, IL-17A, interferon-γ , tumor necrosis factor-α , and granulocyte macrophage 
colony-stimulating factor) in culture supernatants of IECs exposed to purified OMVs LB226692 (470 ng/
ml of protein containing 58 ng/ml of Stx2a and 80 ng/ml of flagellin; plus 950 ng/ml of LPS) or OMVs 
C227-11Φ cu (470 ng/ml of protein containing 80 ng/ml of flagellin; plus 950 ng/ml of LPS) was deter-
mined with the Multi-Analyte ELISArray kit (Qiagen). IL-8 production elicited by OMVs, H4 flagellin, 
and O104 LPS was quantified with the Single-Analyte IL-8 ELISArray (Qiagen). To determine the contri-
bution of OMV-associated flagellin, IL-8 was quantified in cells exposed for 24 h to: (i) OMVs or isolated 
flagellin (80 ng/ml) without antibodies; (ii) OMVs or flagellin which had been preincubated with rabbit 
anti-H4 antibody (1 h, 37 °C); (iii) OMVs or flagellin after cell pre-incubation with rat anti-TLR5 neutral-
ising antibody (1 h, 37 °C); (iv) OMVs or flagellin preincubated with anti-H4 antibody after cell pretreat-
ment with anti-TLR5 antibody. OMVs or flagellin preincubated with preimmune rabbit serum and cells 
preincubated with preimmune rat IgG served as controls. To assess the contribution of OMV-associated 
LPS, IL-8 was quantified in cells incubated (24 h) with untreated OMVs or isolated O104 LPS (950 ng/
ml) or with OMVs or LPS which had been preincubated (1 h) with polymyxin B (100 μ g/ml) (Sigma). To 
determine the minimum doses of OMV-associated flagellin and LPS capable of eliciting IL-8 secretion, 
IL-8 was quantified in cells exposed to 10-fold OMV dilutions which contained flagellin and LPS (flagel-
lin/LPS) in the amounts of 100 ng/1188 ng/ml, 10 ng/118.8 ng/ml, and 1 ng/11.88 ng/ml, respectively.
www.nature.com/scientificreports/
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Statistical analysis. Data were analysed with one-way ANOVA (analysis of variance) and two-tailed 
unpaired Student’s t test; P values < 0.05 were considered significant.
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